Corporate Giving

We believe in supporting the programs, policies, and initiatives that positively impact the lives of patients with rare, debilitating neuromuscular and neurological diseases.

Catalyst Pharmaceuticals has worked with and provided framework support to the following organizations.

 

Global Genes: 2017 Rare Patient Advocacy Symposium

National Organization for Rare Disorders (NORD)

Global Genes: Tribute to Champions of Hope

University of California Irvine Health 2017 Neuromuscular Colloquium

Global Genes: 2017 RARE Corporate Alliance member

Child Neurology Foundation

Myasthenia Gravis Foundation of America, Inc.

Kansas University Neurological Foundation

Medical Students in Action

Global Genes: 2017 Rare Patient Advocacy Symposium

 

National Organization for Rare Disorders (NORD)

 

Global Genes: Tribute to Champions of Hope

 

University of California Irvine Health 2017 Neuromuscular Colloquium

 

Global Genes: 2017 RARE Corporate Alliance member

 

Child Neurology Foundation

 

Myasthenia Gravis Foundation of America, Inc.

 

Medical Students in Action

 

Kansas University Neurological Foundation

 

Catalyst is a member of Biotechnology Innovation Organization and BioFlorida

Pipeline

.

Investigator-Sponsored Research

.